Publications

Schwartzberg L, Crawford J, Baird J, Crist K, Marino V, Shah N, Franklin H. CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41911759

Moss W, Torres R, Sablan JP, Tenorio L, West J, Sabino A, Kwon D, Brett P, Paulino Y, Warnakulasuriya S. Areca nut policy developments in the Asia-Pacific: Warning labels. Journal of Cancer Policy. 2026. PMID: 41921913

Rugo HS, Pluard TJ, Sharma P, Melisko M, Al-Jazayrly G, Ji Y, Vidula N, Ellerton J, Smakal M, Zimovjanova M, Weng D. OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer. Breast cancer research and treatment. 2026. PMID: 41910867

Rugo HS, Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Lynce F, Cottu P, Thill M, Curigliano G. Real-world progression-free survival 2 (PFS2) and tumor response of CDK4/6 inhibitors plus an aromatase inhibitor in patients with HR+/HER2- metastatic breast cancer in US routine clinical practice. Breast (Edinburgh, Scotland). 2026. PMID: 41950642

Pan D, Mouhieddine TH, Sheng T, Fu W, Moshier E, Richter J, Parekh S, Jagannath S, Chari A, Rossi AC, Sanchez LJ, Thibaud S, Rodriguez C, Cho HJ, Richard S. Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma. Bone marrow transplantation. 2026. PMID: 41912833

Poissonnier A, Rugo HS, Horton W, Kim T, DeLuca A, Egeland EV, Cotechini T, Sivagnanam S, Mori M, Yu Y, Park B, Beelen N, Murugan D, Kirchberger N, Kummar S, Mayer IA, Blackwell K, Hwang ES, Coussens LM. CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41894563

Song H, Xu J, Velazquez-Arcelay K, Demirci A, Raizenne BL, Hsu SC, Choi J, Pham JH, Chen YA, Weinstein HNW, Salzman I, Tsui M, Akutagawa J, Adingo W, Goldschmidt E, Carroll PR, Hong JC, Heaphy CM, Cooperberg MR, Greenland N, Campbell JD, Huang FW. A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasis. bioRxiv : the preprint server for biology. 2026. PMID: 41928983

Fu S, Li G, Ming K, Wang J, Guan H, Ai W, Cheng S, Xu Y, Huang L, Xu Z, Fang G, Ke W. Internal Ultrathin Hydrophobic Self-Assembled Capping Layers Enables Moisture-Resistant All-Perovskite Tandems. Advanced materials (Deerfield Beach, Fla.). 2026. PMID: 41885114

Gounder M, Schöffski P, Jones RL, Stacchiotti S, Demetri GD, Cote GM, Agulnik M, Chugh R, Jahan T, Gupta AA, Chen TW, Ratan R, Dileo P, Drilon A, Malouf GG, Szanto A, Gupta N, Tannir NM. Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study. Nature communications. 2026. PMID: 41882006

Wolff D, Solano C, Michonneau D, Bonifazi F, Mehra V, Hall K, Lazaryan A, Lee CJ, Logan AC, van der Laan M, Gruber S, Kabadi S, Khan I, Nicholls C, Rota L, Nikai E, Ponomareva E, Koumas A, Waller EK, ROCKreal Investigators. Transportability to the European Population of Efficacy of Belumosudil as Compared With Physician's Choice of Best Available Therapy for the Treatment of Chronic Graft Versus Host Disease. Transplantation and cellular therapy. 2026. PMID: 41895695

Wagner AD, Raeisi M, Rakez M, Diasio RD, Margalit O, Zalcberg JR, Venook AP, Douillard JY, Lenz HJ, Heinemann V, Goldberg RM, van Cutsem E, Schmoll HJ, Shi Q, André T, de Gramont A. Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database. European journal of cancer (Oxford, England : 1990). 2026. PMID: 41903302

Kulshrestha A, Patel N, Mellacheruvu P, Aggarwal R, Bhatt DL. Revisiting the healthy immigrant effect: Cardiovascular outcomes among US immigrants in a contemporary national cohort. American journal of preventive cardiology. 2026. PMID: 42403456

McKay RR, Ajmera A, Atkins MB, Barata PC, Bergerot C, Bukavina L, Choueiri TK, Desai A, Hakimi AA, Poteat S, Powles T, Rini BI, Shuch B, Signoretti S, Siva S, Xu W, Yip W, Zhang T, Pal SK. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0. Journal for immunotherapy of cancer. 2026. PMID: 41871874

Okore LA, Aggarwal R, Awuor DR, Owuor PM. Knowledge, attitudes, behaviors, and consequences of geogenic fluoride exposure on oral and dental health in Nakuru, Kenya. Frontiers in oral health. 2026. PMID: 41939973

Varga C, Robinson M, Davis JA, Hashmi H, Martin TG, Kumar A, Sborov DW, Wagner CB, Hansen DK, Castaneda Puglianini O, Shune L, Bhurtel E, Afrough A, Anderson LD, Dhakal B, Herr MM, Richard S, Lieberman-Cribbin A, Sherbenou D, Forsberg PA, Purvey S, Khouri J, Lin Y, Sidana S, Patel KK, Kocoglu M, Midha S, Ferreri CJ. Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium. Blood cancer journal. 2026. PMID: 41862439

Xiao S, Wang M, Martin TG, Scott B, Fang X, Liu X, Yang Y, Fu S, Truong SD, Gugel JF, Maas GL, Mullen MP, Hill JH, Li VL, Markhard AL, Zhao M, Qi W, Reghupaty SC, Zhao M, Spaas J, Wei W, Moholdt T, Hawley JA, Voldstedlund CT, Richter EA, Chen X, Svensson KJ, Bernstein D, Leinwand LA, Xu Y, Long JZ. Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway. Nature metabolism. 2026. PMID: 41857429

Rugo HS, Tolaney SM, Cortés J, Marmé F, de Azambuja E, Xu B, Sohn J, Naito Y, Valdez T, Gary D, Zhu J, Lai C, Bardia A. Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia. ESMO open. 2026. PMID: 41861751

Murthy RK, O'Brien BJ, Berry DA, Singareeka-Raghavendra A, Monroe MG, Johnson J, White J, Schwartz-Gomez J, Topletz-Erickson A, Lobbous M, Riley K, Melisko M, Morikawa A, Ferguson SD, de Groot JF, Krop IE, Valero V, Rimawi MF, Wolff AC, Tripathy D, Lin NU, Stringer-Reasor EM. Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results. Nature cancer. 2026. PMID: 41851506

Nyberg WA, Bernard PL, Ngo W, Wang CH, Ark J, Rothrock A, Borgo GM, Kimmerly GR, Jung JH, Allain V, Hamilton JR, Baldwin A, Stickels R, Wyman S, Khan SH, Lang S, Marsh D, Almudhfar N, Novick C, Mortazavi Y, Zhang S, AbdElwakil MM, Sandoval LR, Hwang S, Chu SN, Jung H, Liu C, Sharma D, McCreary T, Li Z, Satpathy AT, Carnevale J, Rutishauser RL, Cromer MK, Roybal KT, Dodgson SE, Doudna JA, Asokan A, Eyquem J. In vivo site-specific engineering to reprogram T cells. Nature. 2026. PMID: 41851456

O'Neill AF, Zeme EL, Abou-Alfa GK, Baretti M, Bondoc AJ, Church A, Ferrone CR, Fitzgerald M, Geller JI, Gill AE, Harris WP, Kim HB, Lee SS, Liu KX, Ortiz MV, Rangaswami A, Riehle KJ, Rosenberg AR, Torbenson MS, Yarchoan M, Gordan JD. Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma. Hepatology (Baltimore, Md.). 2026. PMID: 41849750